BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
CYP51
,
T cell differentiation
,
Inflammatory disorder
,
Pancreas
,
Biofuel
,
Tamoxifen
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
syndecan 3
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Adrenal gland cortex
Spinal cord
Fetal brain
Substantia nigra
Hypothalamus
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Viremia
Pharyngitis
Diarrhea
Mucopolysaccharidosis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
lonidamine
FluLaval
Adenosine
Prazosin Hydrochloride
ubiquinol
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
RIPK1
HFE
NR5A1
CAMK2D
G3BP1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Syndecan-3 regulates the time of transition from cell cycle exit to initial differentiation stage in…
Distinct effects of SDC3 and FGFRL1 on selective neurodegeneration in AD and PD.
Syndecan-3 as a Novel Biomarker in Alzheimer's Disease.
Hypoxia Promotes Syndecan-3 Expression in the Tumor Microenvironment.
Small intestine submucosa as a growth factor attractor promotes peripheral nerve regeneration by enh…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Effect of Lower Intraabdominal Pressure on Syndecan-1, sVEGF-R2, Occludin, KIM-1, and IL-6 on Li…
The Effect of Anesthetics Agents on Vascular Injury and Level of Syndecan-1 During Knee Surgery
TWICE-IRI: Optimization of Second-line Therapy With Aflibercept, Irinotecan (Day 1 or Day 1,3), 5-Fl…
Degradation of the Glycocalyx in Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage
Cardiogenic Shock Integrated PHenotyping for Event Reduction
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ